CSN Stock Overview
Chesnara plc, together with its subsidiaries, operates in life assurance and pension businesses primarily in the United Kingdom, the Netherlands, and Sweden.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 4/6 |
Chesnara plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£2.52 |
| 52 Week High | UK£2.90 |
| 52 Week Low | UK£2.43 |
| Beta | 0.40 |
| 1 Month Change | -7.18% |
| 3 Month Change | -4.18% |
| 1 Year Change | -10.16% |
| 3 Year Change | -8.36% |
| 5 Year Change | -31.89% |
| Change since IPO | 124.00% |
Recent News & Updates
Recent updates
Chesnara's (LON:CSN) Dividend Will Be Increased To UK£0.15
Apr 03
We Think Shareholders May Want To Consider A Review Of Chesnara plc's (LON:CSN) CEO Compensation Package
May 12Is Chesnara plc (LON:CSN) A Strong Dividend Stock?
Mar 26What Type Of Shareholders Make Up Chesnara plc's (LON:CSN) Share Registry?
Mar 04If You Had Bought Chesnara's (LON:CSN) Shares Three Years Ago You Would Be Down 30%
Feb 12Chesnara plc (LON:CSN) On An Uptrend: Could Fundamentals Be Driving The Stock?
Jan 22
Are Dividend Investors Making A Mistake With Chesnara plc (LON:CSN)?
Dec 18What Kind Of Shareholders Own Chesnara plc (LON:CSN)?
Nov 30Shareholder Returns
| CSN | GB Insurance | GB Market | |
|---|---|---|---|
| 7D | 0% | 1.9% | 1.0% |
| 1Y | -10.2% | -12.7% | 3.0% |
Return vs Industry: CSN exceeded the UK Insurance industry which returned -12.5% over the past year.
Return vs Market: CSN underperformed the UK Market which returned 3.5% over the past year.
Price Volatility
| CSN volatility | |
|---|---|
| CSN Average Weekly Movement | 3.0% |
| Insurance Industry Average Movement | 4.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.4% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: CSN has not had significant price volatility in the past 3 months.
Volatility Over Time: CSN's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO |
|---|---|---|
| 2003 | 419 | Steve Murray |
| Website |
|---|
| www.chesnara.co.uk |
Chesnara plc, together with its subsidiaries, operates in life assurance and pension businesses primarily in the United Kingdom, the Netherlands, and Sweden. It operates through UK, Movestic, Waard Group, and Scildon segments. The company underwrites life risks, such as death, disability, health, and accident; and provides a portfolio of investment contracts for the savings and retirement needs of customers through asset management, as well as general insurance products.
Chesnara plc Fundamentals Summary
| CSN fundamental statistics | |
|---|---|
| Market cap | UK£380.40m |
| Earnings (TTM) | UK£18.70m |
| Revenue (TTM) | UK£389.10m |
20.3x
P/E Ratio1.0x
P/S RatioIs CSN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CSN income statement (TTM) | |
|---|---|
| Revenue | UK£389.10m |
| Cost of Revenue | UK£179.00m |
| Gross Profit | UK£210.10m |
| Other Expenses | UK£191.40m |
| Earnings | UK£18.70m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Jun 30, 2024
| Earnings per share (EPS) | 0.12 |
| Gross Margin | 54.00% |
| Net Profit Margin | 4.81% |
| Debt/Equity Ratio | 57.8% |
How did CSN perform over the long term?
See historical performance and comparison